Frequency and outcomes of BRAF alterations identified by liquid biopsy in metastatic, non-colorectal gastrointestinal cancers.

Background Impact of BRAF V600E mutations (BRAF V600E), a poor prognostic factor in metastatic colorectal cancer, is lacking in non-CRC gastrointestinal (GI) cancers including pancreatic (PDAC), gastric/gastroesophageal (GEA), hepatocellular carcinoma (HCC), and cholangiocarcinoma (CCA). Due to tumo...

Full description

Bibliographic Details

Published in:	Oncologist Vol. 30; no. 3; pp. 1 - 10
Main Authors:	Mahipal, Amit, Bucheit, Leslie, Zhang, Nicole, Barnett, Reagan M, Storandt, Michael H, Chakrabarti, Sakti
Format:	research tables/charts Journal Article
Published:	Oxford University Press / USA Mar2025
Online Access:	View this record in EBSCOhost